By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
BELBUCA221.65M28.40%
Xtampza Extended-release (ER)199.31M25.53%
Jornay PM148.86M19.07%
Nucynta Immediate-release (IR)115.31M14.77%
Nucynta Extended-release (ER)80.99M10.38%
Symproic14.45M1.85%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States780.57M100.00%